Comparison
48 Xyyy Syndrome C4518082 vs 2 Hydroxyglutarate Aciduria C5139239
Clinical comparison between 48 Xyyy Syndrome and 2 Hydroxyglutarate Aciduria for differential diagnosis and treatment planning.
48 Xyyy Syndrome C4518082
A very rare chromosomal condition in males with extra Y chromosomes, associated with severe intellectual disability and physical abnormalities.
2 Hydroxyglutarate Aciduria C5139239
A metabolic disorder causing buildup of 2-hydroxyglutaric acid. It may affect the brain and nervous system. Management includes supportive therapies and monitoring for complications.
6 comparison axes
Onset
48 Xyyy Syndrome C4518082
Variable
2 Hydroxyglutarate Aciduria C5139239
0-10
Onset patterns differ
Severity
48 Xyyy Syndrome C4518082
severe
2 Hydroxyglutarate Aciduria C5139239
moderate
Different severity levels
Chronic
48 Xyyy Syndrome C4518082
Chronic
2 Hydroxyglutarate Aciduria C5139239
Chronic
Differing course
Communicable
48 Xyyy Syndrome C4518082
No
2 Hydroxyglutarate Aciduria C5139239
No
Different transmission
Body System
48 Xyyy Syndrome C4518082
congenital
2 Hydroxyglutarate Aciduria C5139239
metabolic
Same/different system
Category
48 Xyyy Syndrome C4518082
genetic
2 Hydroxyglutarate Aciduria C5139239
metabolic
Different category
Bottom line
48-xyyy-syndrome-C4518082 and 2-hydroxyglutarate-aciduria-C5139239 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 48 Xyyy Syndrome C4518082 | 2 Hydroxyglutarate Aciduria C5139239 | Discriminating power |
|---|---|---|---|
| Developmental impairment | Severe intellectual disability is described. | Brain or nervous-system effects may occur; severity is not fixed here. | Moderate |
| Physical features | Physical abnormalities are associated. | No specific congenital body phenotype is supplied. | Moderate |
| Age pattern | Onset is listed as variable. | Supplied onset range is childhood, ages 0–10. | Moderate |
When to favor each condition
Choose 48 Xyyy Syndrome C4518082 when
Male with suspected extra Y chromosomes
The source defines a chromosomal condition in males.
High
Congenital genetic evaluation
It is classified as congenital and genetic, not a metabolic aciduria.
High
Severe disability with physical abnormalities
Those associations are specifically supplied for this condition.
Moderate
Choose 2 Hydroxyglutarate Aciduria C5139239 when
Suspected 2-hydroxyglutaric acid buildup
The condition is defined by accumulation of this metabolite.
High
Childhood neurologic presentation
Onset is listed as 0–10 and the nervous system may be affected.
Moderate
Metabolic rather than karyotype question
Its category and body system are metabolic.
High
How key tests differ
| Test | 48 Xyyy Syndrome C4518082 | 2 Hydroxyglutarate Aciduria C5139239 | Interpretation |
|---|---|---|---|
| Karyotype or chromosomal analysis | May identify extra Y chromosomes in a male. | Not the defining test for this aciduria. | Supports a chromosomal suspicion; confirmation belongs to a clinician. |
| Organic-acid or 2-hydroxyglutarate testing | Not described as the defining test. | May show elevated 2-hydroxyglutaric acid; no cutoff is supplied. | An abnormal metabolite result suggests, but does not alone diagnose, the disorder. |
| Neurodevelopmental assessment | May document severe intellectual disability. | May document variable neurologic involvement. | Clinical overlap is possible, so testing must match the suspected cause. |
Prognosis comparison
48 Xyyy Syndrome C4518082
- Outcome
- A severe chronic course is suggested, but survival and functional outcomes are not established.
- Factors
- Intellectual disability, physical abnormalities, and support needs.
2 Hydroxyglutarate Aciduria C5139239
- Outcome
- A moderate chronic metabolic course is suggested; exact outcomes are not established.
- Factors
- Neurologic involvement, metabolic findings, and complication monitoring.
Time frame: Chronic or potentially lifelong; no exact timeline is supplied.
Cause, severity, age at recognition, and supportive care may matter, but evidence is limited.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurologic or cognitive impairment | Severe intellectual disability is described. Nervous-system involvement may occur; extent is not established. Functional impact should be assessed individually. |
| Physical abnormalities | Associated in the source description. Not specifically described here. A shared congenital phenotype should not be assumed. |
| Long-term care needs | Chronic congenital condition. Chronic disorder managed with supportive care and monitoring. Specific complications, doses, and outcomes are not supplied. |
Patient education highlights
- HighDifferent causes
One is a rare sex-chromosome condition; the other involves metabolic acid buildup. They are not interchangeable.
- HighTest interpretation
Chromosome and metabolic tests answer different questions. Abnormal findings need clinician review.
- MediumOngoing care
Both are described as chronic. Exact treatments, risks, and outcomes are not established here.